Fibrocell Science, Inc. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Fibrocell Science, Inc. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $97.06 million as of 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2013-11-14
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $97.06M.
- 2013-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $84.12M.
- 2013-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $77.92M.
- 2012-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $72.08M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2013-09-30 | $97.06M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $84.12M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $77.92M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $72.08M 10-Q · filed 2013-11-14 |
| 2012-06-30 | $64.30M 10-Q · filed 2012-08-14 |
| 2011-12-31 | $49.35M 10-K · filed 2013-04-01 |